CombiGene AB (COJ0) Stock Statistics & Valuation Metrics

CombiGene AB has a market cap or net worth of €4.08M. The enterprise value is -€14.34M.

CombiGene AB has 19,801,197 shares outstanding. The number of shares has decreased by -2.65% in one year.

CombiGene AB’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -23.38%.

The current PE Ratio of CombiGene AB is ―. CombiGene AB’s PEG ratio is 0.05.

In the last 12 months, CombiGene AB had revenue of 0.00 and earned -12.36M in profits. Earnings per share was -0.62.

In the last 12 months, operating cash flow was -12.78M and capital expenditures 0.00, giving a free cash flow of -12.78M billion.

CombiGene AB pays an annual dividend of ―, resulting in a dividend yield of ―

CombiGene AB upcoming earnings date is Aug 21, 2026, TBA (Confirmed).

CombiGene AB as a current ratio of 5.37, with Debt / Equity ratio of 0.00%

In the past 12 months, CombiGene AB has paid 0.00 in taxes.

CombiGene AB EV to EBITDA ratio is -5.87, with an EV/FCF ratio of -3.30.

CombiGene AB has €5.84M in cash and marketable securities with €0.00 in debt, giving a net cash position of €5.84M billion.

Gross margin is -1515.13%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for CombiGene AB is ―, which is 11.43% higher than the current price. The consensus rating is ―